Skip to search formSkip to main contentSkip to account menu

chiron vaccine

Known as: chiron 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Viral Vaccines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
A chiron approach to the total synthesis of cytotoxic (+)-muricatacin and (+)-5-epi-muricatacin from D-ribose.
2008
2008
Chiron approach to the synthesis of (2S,3R)-3-hydroxypipecolic acid and (2R,3R)-3-hydroxy-2-hydroxymethylpiperidine from D-glucose.
The first chiron approach from d-glucose for the total synthesis of (2 S,3 R)-3-hydroxypipecolic acid (-)-1a and (2R,3R)-3… 
2001
2001
Phase II Trial of Systemic Recombinant Interleukin-2 in the Treatment of Refractory Nasopharyngeal Carcinoma
Background: Interleukin-2 (IL-2) is a cytokine produced by activated T cells, which has shown powerful immunostimulatory and… 
Review
2001
Review
2001
Safety of a new conjugate meningococcal C vaccine in infants
BACKGROUND Group C conjugate meningococcal vaccines (Men C) were introduced into the UK primary immunisation schedule in November… 
Highly Cited
1998
Highly Cited
1998
Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines. Stage II Working Group.
Review
1998
Review
1998
HIV vaccine development: a subtype E-specific strategy.
The pandemic of HIV/AIDS consists of multiple foci with distinct epidemiological characteristics. Among the approximately one… 
1997
1997
Safety and immunogenicity of Chiron/Biocine recombinant acellular pertussis-diphtheria-tetanus vaccine in infants and toddlers.
OBJECTIVE To evaluate the safety and immunogenicity of the recombinant acellular pertussis-diphtheria-tetanus (aPDT) vaccine (C… 
Review
1996
Review
1996
Safety and Immunogenicity of a Candidate HIV-1 Vaccine in Healthy Adults: Recombinant Glycoprotein (rgp) 120: A Randomized, Double-Blind Trial
Development of a vaccine is crucial for controlling the global epidemic of human immunodeficiency virus type 1 (HIV-1) infection… 
Review
1993
Review
1993
Jitters jeopardize AIDS vaccine trials.
AIDS vaccine developers have been planning large-scale tests of experimental vaccines in people at high risk of becoming infected… 
1990
1990
Antibodies to hepatitis C virus in blood donors
Recently a recombinant polypeptide of hepatitis C virus (HCV) has been developed by the Chiron Corporation in California. This… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)